I-KEMSA iQalisa uPhicotho-zincwadi lwesitokhwe sikaZwelonke ukuze kuphuculwe ukuChaneka kunye nokukhuthaza iiNkonzo zeMpilo zoLuntu
Kutshanje, i-Shenzhen Institutes of Advanced Technology ye-Chinese Academy of Sciences yapapasha isiphumo sophando olusisiseko kwiNature Nanotechnology. Inkqubo ye-nanorobot yamagnetic ephuhliswe ngabo iye yafumana okokuqala unyango olupheleleyo "lokuwela umqobo wegazi-ingqondo - ukuhamba okuchanekileyo - ukuqhuma okujoliswe kuyo", ukuzisa isisombululo soguquko kwizifo zengqondo ezifana nesifo se-Alzheimer.
Washington, Juni 12, 2024 - I-US Food and Drug Administration (FDA) namhlanje ikhawulezise ukuvunywa konyango lwemfuza "SOD1-ASO" (igama lophawu lwe-Toferson) ephuhliswe yi-Swiss pharmaceutical giant Novartis kunyango lwe-amyotrophic lateral sclerosis (ALS) ebangelwa ukuguqulwa kwe-supergene dismutase (SOD1). Eli lichiza lokuqala lonyango lwemfuza elijolise kuhlobo oluthile lwe-ALS.
Uphando lwamva nje lubonisa ukuba ukungabikho kokulala kwexesha elide akukhokelela kuphela ekudinweni nasekunciphiseni imemori, kodwa kunokonyusa umngcipheko wesifo i-Alzheimer's. Iingcali zenzululwazi ziye zafumanisa ukuba ngexesha lokulala, ingqondo iqala "indlela yokucoca" ukususa iiprotheni ezinobungozi, kwaye ukuhlala kude kube sebusuku kuphazamisa le nkqubo, ukukhawuleza ukuhla kwengqondo.
Ingxelo yamva nje evela kwi-WHO ilumkisa ukuba ingxaki yokunganyangeki ngamayeza okubulala iintsholongwane iyakhula ngokukhawuleza. Ukuba akusingathwanga ngokungxamisekileyo, kusenokubangela ukufa kwamashumi ezigidi zabantu ehlabathini lonke kwiminyaka elishumi ezayo, nto leyo esongela isiseko senkqubo yezonyango yanamhlanje.
I-EU ivume ukuphumelela kwe-Alzheimer's drug donanemab, eboniswa ukuhla ngokucotha kwengqondo nge-35%, kodwa ixabiso layo le-$ 30,000 yonyaka liphakamisa iinkxalabo zokufikeleleka kwizigulane kwihlabathi jikelele.